SCHEMBL7236294

SCHEMBL7236294

CCC(CC[C@@H]1C[C@@H](C(=O)O)C[C@H]1N)C(C)CNC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232829 0.82 — —
SCHEMBL7242472 0.82 — —
SCHEMBL7232199 0.77 — —
Hydrochloric Acid SCHEMBL7233626 0.76 SLC6A12 (0.30) —
SCHEMBL5722385 0.71 SLC6A12 (0.39) —
SCHEMBL7230793 0.68 MTNR1A (0.34) —
SCHEMBL7898944 0.68 NEU2 (0.31) —
SCHEMBL7231029 0.66 NEU2 (0.34) —
SCHEMBL4413704 0.66 NEU2 (0.34) —
SCHEMBL7232568 0.64 NEU2 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562861-B1 (1R,3R,4R,1'S)-(-)-(1'-acetylamino-2 '-ethyl)butyl-4-(aminoimino)methylaminocyclopentan-1-carboxylic acid was prepd. and tested in vitro as neuraminidase inhibitor (IC50 less-than 1.mu.M). Bactericides or viricides BIOCRYST PHARMACEUTICALS, INC. 2003-05-13 — — US claimed
Send feedback